- $498.49m
- $190.96m
- $9.68m
Annual balance sheet for Prothena, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 579 | 710 | 619 | 471 | 308 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | — | 5.16 | 0 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 585 | 719 | 639 | 485 | 315 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14.1 | 8.01 | 16 | 13.8 | 10.3 |
| Other Long Term Assets | |||||
| Total Assets | 609 | 758 | 696 | 547 | 327 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 33.5 | 50.1 | 56.9 | 48.5 | 40.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 143 | 136 | 135 | 60.2 | 46.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 466 | 622 | 561 | 487 | 280 |
| Total Liabilities & Shareholders' Equity | 609 | 758 | 696 | 547 | 327 |
| Total Common Shares Outstanding |